19 completed. 19 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 19 | Completed 19 |
| Phase 2 | 6 | Completed 6 |
Follow Benign Prostatic Hyperplasia: new trials by email Literature Review of Benign Prostatic Hyperplasia trials Research Report on Benign Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers AD-116, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Addpharma Inc. | 44 | 2026-01-22 | 2026-07-28 |
| BOTOX Injection Technique for LUTS Due to BPH Botulinum Toxin Type A (BoNT-A) - Benign Prostatic Hyperplasia | Phase 1 | Completed | Benha University | 60 | 2025-10-01 | 2026-06-12 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia VGH-BPH1, Placebo (Corn starch pill manufactured to mimic VGH-BPH1) - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Taipei Veterans General Hospital, Taiwan | 23 | 2019-03-06 | 2020-04-13 |
| Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Dutasteride 0.5 mg, Tadalafil 5 mg, YY-201 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Yuyu Pharma, Inc. | 36 | 2017-03-27 | 2017-11-24 |
| Study to Compare the Safety and Pharmacokinetics of CKD-397 CKD-397, TD+TM - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 36 | 2015-11-01 | 2016-01-12 |
| The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. JLP-1207, Solifenacin 5mg+Tamsulosin 0.2mg - LUTS(Lower Urinary Tract Symptoms), Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 54 | 2015-08-01 | 2016-06-24 |
| Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers JLP-1207(Fasted), JLP-1207(Fed) - LUTS, Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 54 | 2015-07-01 | 2016-06-24 |
| Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin Tamsulosin, Solifenacin, Tamsulosin and solifenacin - LUTS, Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 36 | 2014-07-01 | 2016-06-24 |
| Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin Tadalafil, Tamsulosin, Tadalafil + Tamsulosin - Erectile Dysfunction, Benign Prostatic Hyperplasia | Phase 1 | Completed | Hanmi Pharmaceutical Company Limited | 30 | 2014-03-01 | 2014-09-12 |
| Prostate Embolization for Benign Prostatic Hyperplasia Prostatic Embolization with Embosphere Micropsheres - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | James B. Spies, MD | 15 | 2013-08-01 | 2019-12-10 |
| Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) PRX302, Placebo - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Sophiris Bio Corp | 40 | 2011-09-01 | 2013-08-21 |
| A Study of Tadalafil in Benign Prostatic Hyperplasia Tadalafil - Benign Prostatic Hyperplasia | Phase 1 | Completed | Eli Lilly and Company | 24 | 2010-07-01 | 2012-05-16 |
| A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia Botulinum Toxin Type A, Placebo (saline) - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Allergan | 61 | 2009-08-01 | 2013-09-30 |
| EC905 Pharmacokinetic Profile Study Tamsulosin HCl, Solifenacin Succinate, EC905 - Phase 1, Healthy | Phase 1 | Completed | Astellas Pharma Europe B.V. | 46 | 2009-03-01 | 2015-12-18 |
| Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Talaporfin sodium, Placement of device in prostate urethra, Transurethral illumination with light emitting diodes (Litx™ BPH Device) - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 1 | Completed | Light Sciences Oncology | 12 | 2008-06-01 | 2012-11-16 |
| Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia QLT0074, Photodynamic therapy - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | QLT Inc. | 2003-03-01 | 2012-05-23 | |
| Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) dehydrated alcohol - Prostate Disease, BPH | Phase 1 / Phase 2 | Completed | American Medical Systems | 150 | 2002-03-01 | 2007-10-10 |
Prostatic Hyperplasia (19) · Lower Urinary Tract Symptoms (5) · Urinary Bladder, Overactive (4) · Erectile Dysfunction (1) · Prostatic Diseases (1) · Prostatitis (1) · Urinary Bladder Neck Obstruction (1) · Urinary Incontinence (1)
Genital Diseases (19) · Genital Diseases, Male (19) · Male Urogenital Diseases (19) · Urogenital Diseases (19) · Prostatic Diseases (18) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Urological Manifestations (7) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Urinary Bladder Diseases (4) · Urologic Diseases (4) · Lower Urinary Tract Symptoms (2) · Mental Disorders (1) · Sexual Dysfunction, Physiological (1)
Tamsulosin (4) · Solifenacin Succinate (3) · Tadalafil (3) · Botulinum Toxins, Type A (2) · Dutasteride (1) · Embryo Implantation (1) · Ethanol (1) · PRX302 (1) · Photochemotherapy (1) · QLT0074 (1) · Sodium Chloride (1) · Starch (1) · Talaporfin (1) · incobotulinumtoxinA (1)
Chong Kun Dang Pharmaceutical (3) · Jeil Pharmaceutical Co., Ltd. (3) · Addpharma Inc. (1) · Allergan (1) · American Medical Systems (1) · Astellas Pharma Europe B.V. (1) · Benha University (1) · Eli Lilly and Company (1) · Hanmi Pharmaceutical Company Limited (1) · James B. Spies, MD (1) · Light Sciences Oncology (1) · QLT Inc. (1) · Sophiris Bio Corp (1) · Taipei Veterans General Hospital, Taiwan (1) · Yuyu Pharma, Inc. (1)
South Korea (7) · United States (5) · Canada (1) · Egypt (1) · Germany (1) · Netherlands (1) · Taiwan (1)
Kyung-sang Yu, M.D., Ph.D. (2) · Yu-Jung Cha (2) · Hyeong-Seok Lim, M.D.,Ph.D. (1) · Kyung-sang Yu, M.D.,Ph.D. (1) · Min Kyu Park, MD, PhD (1) · Richard C. Yocum, MD (1) · Shinn-Jang Hwang, M.D. (1) · Sy-Shi Wang, PhD (1)